Maxim Group initiated coverage on Anixa Biosciences with a new price target
$ANIX
Biotechnology: Pharmaceutical Preparations
Health Care
Maxim Group initiated coverage of Anixa Biosciences with a rating of Buy and set a new price target of $10.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/21/2025 | $10.00 | Buy | Maxim Group |
| 12/23/2022 | $8.00 | Buy | Chardan Capital Markets |